Shield Therapeutics PLC (STX) Research Coverage Started at Canaccord Genuity

Posted on July 18, 2016 by

The brokerage set a “buy” rating and a GBX 235 price target on the stock. Shield Therapeutics PLC opened at 155.50 on Monday.

Read the original post by Daily Political